{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:20:09Z","timestamp":1790079609893,"version":"4.0.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Previous findings have indicated that elevated low-density lipoprotein cholesterol (LDL-C) and remnant cholesterol (RC) are associated with hypertension. We aim to explore whether higher RC levels may be associated with hypertension beyond LDL-C in the general US adult population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study included 10,842 adults from the National Health and Nutrition Examination Survey (NHANES) 1999\u20132018. Weighted multivariable logistic regression models were used to estimate the odds ratios (ORs) of hypertension for LDL-C and RC. We also performed analyses examining the association between hypertension and LDL-C vs. RC concordant\/discordant groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 4,963 (41.54%, weighted) individuals had hypertension. The weighted median levels were LDL-C: 118mg\/dL, RC: 20mg\/dL. At lower LDL-C clinical cut-point, the proportion of discordantly high RC dramatically increased. After multivariable adjustment, log RC was associated with higher prevalence of hypertension [OR 2.54, 95% confidence interval (CI) 2.17\u20132.99]. Participants with the highest tertile of RC were more likely to have hypertension (OR 2.18; 95% CI 1.89-2.52) compared with those with the lowest tertile of RC. This association remained marked after including body mass index (BMI), LDL-C, high-density lipoprotein cholesterol (HDL-C) or triglycerides. The association between LDL-C and hypertension was absent after adjusting for BMI, RC or triglycerides. Compared with low LDL-C\/low RC group, the discordant low LDL-C\/high RC group was associated with hypertension (OR 2.04; 95% CI 1.72-2.42), whereas the high LDL-C\/low RC group was not, regardless of BMI, HDL-C or triglycerides. Similar results were observed when examining discordance among different clinical cut-points, except for the cut-point of LDL-C 70 mg\/dL and RC 13 mg\/dL. To better understand the association, we performed an additional analysis, which showed that among participants with apolipoprotein B &amp;lt; median (92mg\/dL), those with discordant RC \u2265 median (20mg\/dL) had significantly higher odds of having hypertension (OR 1.73; 95% CI 1.38-2.17).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>RC was associated with hypertension beyond LDL-C in the general US adult population. This association went beyond increased triglycerides levels, and lipoproteins other than apoB may be involved.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1260764","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T14:00:13Z","timestamp":1695996013000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Remnant cholesterol associates with hypertension beyond low-density lipoprotein cholesterol among the general US adult population"],"prefix":"10.3389","volume":"14","author":[{"given":"Liu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yewen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuye","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"B1","first-page":"1","article-title":"Deaths: final data for 2017","volume":"68","author":"Kochanek","year":"2019","journal-title":"Natl Vital Stat Rep"},{"key":"B2","unstructured":"Hypertension Cascade: Hypertension Prevalence, Treatment and Control Estimates among U.S. Adults Aged 18 Years and Older"},{"key":"B3","first-page":"0214680.003.001.001","article-title":"Projections of cardiovascular disease prevalence and costs: 2015-2035","volume-title":"Tech Rep","author":"Nelson","year":"2016"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.010676","article-title":"Hypertension in the United States, 1999 to 2012: progress toward healthy people 2020 goals","volume":"130","author":"Egan","year":"2014","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4158\/CS-2020-0490","article-title":"Consensus statement by the American association of clinical endocrinologists and american college of endocrinology on the management of dyslipidemia and prevention of cardiovascular disease algorithm - 2020 executive summary","volume":"26","author":"Handelsman","year":"2020","journal-title":"Endocr Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab432","article-title":"Remnant cholesterol predicts cardiovascular disease beyond Ldl and Apob: A primary prevention study","volume":"42","author":"Quispe","year":"2021","journal-title":"Eur Heart J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not Ldl cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Castaner","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12933-022-01667-6","article-title":"Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: A nationwide longitudinal cohort study","volume":"21","author":"Huh","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003051","article-title":"Comprehensive biomarker profiling of hypertension in 36 985 finnish individuals","volume":"40","author":"Palmu","year":"2022","journal-title":"J Hypertens"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.951635","article-title":"The association of remnant cholesterol (Rc) and interaction between Rc and diabetes on the subsequent risk of hypertension","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.830347","article-title":"High remnant cholesterol level potentiates the development of hypertension","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12916-023-02733-w","article-title":"Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond Ldl cholesterol","volume":"21","author":"Wu","year":"2023","journal-title":"BMC Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2020.11.026","article-title":"Lipid profiles and the risk of new-onset hypertension in a chinese community-based cohort","volume":"31","author":"He","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B14","unstructured":"National Health and Nutrition Examination Survey"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2021.09.046","article-title":"Lipid measurements in the management of cardiovascular diseases: practical recommendations a scientific statement from the national lipid association writing group","volume":"15","author":"Wilson","year":"2021","journal-title":"J Clin Lipidol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa126","article-title":"New Sampson low-density lipoprotein equation: better than Friedewald and Martin-Hopkins","volume":"66","author":"Koch","year":"2020","journal-title":"Clin Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 Esc\/Eas guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 Aha\/Acc\/Aacvpr\/Aapa\/Abc\/Acpm\/Ada\/Ags\/Apha\/Aspc\/Nla\/Pcna guideline on the management of blood cholesterol: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B20","first-page":"1","article-title":"National health and nutrition examination survey: analytic guidelines, 1999-2010","author":"Johnson","year":"2013","journal-title":"Vital Health Stat 2"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025858","article-title":"Physiological bases for the superiority of apolipoprotein B over low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as a marker of cardiovascular risk","volume":"11","author":"Glavinovic","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-021-01490-0","article-title":"Associations between remnant lipoprotein cholesterol and central systolic blood pressure in a Chinese community-based population: A cross-sectional study","volume":"20","author":"Li","year":"2021","journal-title":"Lipids Health Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.993097","article-title":"Association between remnant cholesterol and arterial stiffness in a Chinese community-based population: A cross-sectional study","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"684","DOI":"10.5551\/jat.63695","article-title":"The association of remnant cholesterol with endothelial dysfunction and subclinical atherosclerosis in a check-up population in China","volume":"30","author":"Yang","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/eurheartj\/ehac783","article-title":"What is 'Remnant cholesterol'","volume":"44","author":"Sturzebecher","year":"2023","journal-title":"Eur Heart J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2019.05.011","article-title":"A third of nonfasting plasma cholesterol is in remnant lipoproteins: lipoprotein subclass profiling in 9293 individuals","volume":"286","author":"Balling","year":"2019","journal-title":"Atherosclerosis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/nu13061774","article-title":"Triglyceride-rich lipoproteins and their remnants as silent promoters of atherosclerotic cardiovascular disease and other metabolic disorders: A review","volume":"13","author":"Sascau","year":"2021","journal-title":"Nutrients"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","volume":"19","author":"Boren","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European atherosclerosis society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30889","article-title":"Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing","volume":"117","author":"Mahley","year":"2007","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.m200322-jlr200","article-title":"Apoc-Iii content of Apob-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan","volume":"43","author":"Olin-Lewis","year":"2002","journal-title":"J Lipid Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000117403.64398.53","article-title":"Remnant lipoprotein particles induce apoptosis in endothelial cells by Nad(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol","volume":"109","author":"Shin","year":"2004","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R700001-JLR200","article-title":"Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase","volume":"48","author":"Zheng","year":"2007","journal-title":"J Lipid Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00184","article-title":"The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk","volume":"40","author":"Sandesara","year":"2019","journal-title":"Endocr Rev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2015.07.001","article-title":"Apolipoprotein C-iii: from pathophysiology to pharmacology","volume":"36","author":"Norata","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13393","article-title":"Sex differences in regional adipose tissue depots pose different threats for the development of type 2 diabetes in males and females","volume":"23","author":"Delaney","year":"2022","journal-title":"Obes Rev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.6.2004","article-title":"Secondhand tobacco smoke impairs rabbit pulmonary artery endothelium-dependent relaxation","volume":"120","author":"Hutchison","year":"2001","journal-title":"Chest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202212","article-title":"Critical role of fractalkine (Cx3cl1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium","volume":"68","author":"Rius","year":"2013","journal-title":"Thorax"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride lowering with pemafibrate to reduce cardiovascular risk","volume":"387","author":"Das Pradhan","year":"2022","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.025071","article-title":"Omega-3 polyunsaturated fatty acids intake and blood pressure: A dose-response meta-analysis of randomized controlled trials","volume":"11","author":"Zhang","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.5551\/jat.45799","article-title":"Bezafibrate ameliorates arterial stiffness assessed by cardio-ankle vascular index in hypertriglyceridemic patients with type 2 diabetes mellitus","volume":"26","author":"Yamaguchi","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002276","article-title":"Statin therapy is associated with better ambulatory blood pressure control: A propensity score analysis","volume":"38","author":"Spannella","year":"2020","journal-title":"J Hypertens"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.5551\/jat.3848","article-title":"Switching to aggressive statin improves vascular endothelial function in patients with stable coronary artery disease","volume":"17","author":"Hoshiga","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-018-1706-1","article-title":"A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and Ldl-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia","volume":"58","author":"Blom","year":"2019","journal-title":"Eur J Nutr"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.279463","article-title":"Remnant cholesterol and myocardial infarction in normal weight, overweight, and obese individuals from the Copenhagen general population study","volume":"64","author":"Varbo","year":"2018","journal-title":"Clin Chem"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1260764\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T14:00:18Z","timestamp":1695996018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1260764\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":47,"alternative-id":["10.3389\/fendo.2023.1260764"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1260764","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"article-number":"1260764"}}